BIOCIDES · TRADE NAMES
Biocides: does your trade name promise too much?
Slovenia’s Chemicals Office is calling for a review of biocidal product trade names. A product name can create a misleading impression of its risks, so check the register, packaging and online sales.
Checked on 17 November 2026.
The trade name of a disinfectant or another biocidal product is more than a branding decision. If it suggests that the product is harmless or particularly environmentally friendly, it may lead to non-compliance. On 22 October 2026, Slovenia’s Chemicals Office published a call to bring trade names into compliance, addressed to authorisation holders and companies that have notified biocidal products.
Why can the name itself be a problem?
Articles 69 and 72 of Regulation (EU) No 528/2012 prohibit misleading labelling and advertising concerning the risks or efficacy of biocides. They expressly cover statements such as “non-toxic”, “harmless” and “natural”, as well as similar claims. Assessment therefore includes the meaning of the name, rather than only the small print on the label.
Under the Court of Justice’s judgment in Case C-296/23, similar indications are not limited to a closed list of words. What matters is whether a statement downplays risks or denies their existence. Consider the overall impression given to users when assessing a particular name.
Registration is not the end of the review
The Chemicals Office notes that the register still includes products whose names were notified or authorised in the past. Such an entry does not itself establish that the name complies with current requirements. For authorised products, the appropriate authorisation change must be arranged; for products notified under the national transitional procedure, a change of name is reported using the notification amendment form.
Before taking action, establish the procedure under which your product is on the market. Renaming it independently in an online shop may create further inconsistencies between the authorisation, supplier documents and actual offer. An internal review and a formal amendment are related but separate steps.
How can you review your portfolio?
We recommend listing all trade names, including other language versions and names used in different sales channels. For each name, record the product’s legal basis, the authorisation holder or notifier and a link to the label. Flag terms that may suggest an absence of risk.
Compare packaging, safety data sheets, catalogues, online shops and distributor materials. Where versions differ, appoint someone to coordinate alignment. Give sales teams clear instructions on the name and description that may be used while the change is being finalised.
Plan changes with your supply chain
For products supplied under another company’s brand, involve the supplier and authorisation holder in the review. Ask who will manage the change and which documents you will receive. For your own brand, also check the implications for product codes, purchase orders and packaging stocks.
We recommend keeping a decision record: the name reviewed, the reason for the change, the proposed solution and the procedure’s status. This helps demonstrate what was checked and prevents the old name from reappearing in an advertisement or another seller’s offer.
Need a review of names and labelling?
BiSafe helps review documentation and requirements for biocidal products. Send the trade names, labels and details of the authorisation or notification to info@bisafe.si. We can then identify the next steps needed.

